Dodge & Cox Baxter International Inc Transaction History

Dodge & Cox

$164 Billion
Q1 2025

A detailed history of Dodge & Cox transactions in Baxter International Inc stock. As of the latest transaction made, Dodge & Cox holds 51,458,925 shares of BAX stock, worth $1.5 Billion. This represents 1.08% of its overall portfolio holdings.

Number of Shares

51,458,925

Previous 50,377,294 2.15%

Holding current value

$1.5 Billion

Previous $1.47 Billion 19.91%

% of portfolio

1.08%

Previous 0.92%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$29.26 - $36.57 $31.6 Million - $39.6 Million	1,081,631 Added 2.15%	51,458,925 $1.76 Billion
Q4 2024 Feb 13, 2025	BUY	$28.63 - $37.84 $165 Million - $219 Million	5,779,100 Added 12.96%	50,377,294 $1.47 Billion
Q3 2024 Nov 13, 2024	BUY	$32.85 - $40.26 $561 Million - $687 Million	17,075,449 Added 62.04%	44,598,194 $1.69 Billion
Q2 2024 Aug 13, 2024	BUY	$32.87 - $43.55 $685,339 - $908,017	20,850 Added 0.08%	27,522,745 $921 Million
Q1 2024 May 14, 2024	BUY	$37.88 - $43.77 $4.56 Million - $5.27 Million	120,430 Added 0.44%	27,501,895 $1.18 Billion
Q4 2023 Feb 15, 2024	BUY	$31.71 - $38.95 $556 Million - $683 Million	17,533,024 Added 178.03%	27,381,465 $1.06 Billion
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $368 Million - $485 Million	9,848,441 New	9,848,441 $372 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $29,827 - $34,876	-400 Reduced 10.58%	3,382 $290,000
Q2 2021 Aug 13, 2021	BUY	$80.5 - $88.01 $32,200 - $35,204	400 Added 11.83%	3,782 $304,000
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $201,229 - $218,511	3,382	3,382 $212,000

Others Institutions Holding BAX

# of Institutions

950

Shares Held

472M

Call Options Held

3.84M

Put Options Held

2.32M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account